C. Rothschild

Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX Inhibitors

Claude Négrier, Jenny Goudemand, Sultan Y et al. · Thrombosis and Haemostasis · 1997 · 281 citations

Medicine, Hematology, Surgery +17

Treatment of severe von Willebrand disease with a high‐purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients

Annie Borel‐Derlon, Augusto B. Federici, V. Roussel‐Robert et al. · Journal of Thrombosis and Haemostasis · 2007 · 123 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

French Previously Untreated Patients with Severe Hemophilia A after Exposure to Recombinant Factor VIII : Incidence of Inhibitor and Evaluation of Immune Tolerance

Y. Laurian, A Derlon, Hérvè Chambost et al. · Thrombosis and Haemostasis · 1998 · 89 citations

Medicine, Hematology, Pharmacology +8

Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data

Michael Richards, Carmen Altisent, Angelika Bátorová et al. · Haemophilia · 2007 · 77 citations

Medicine, Hematology, Pharmacotherapy +13

Can a community health worker administered postnatal checklist increase health-seeking behaviors and knowledge?: evidence from a randomized trial with a private maternity facility in Kiambu County, Kenya

Margaret McConnell, Allison Ettenger, C. Rothschild et al. · BMC Pregnancy and Childbirth · 2016 · 65 citations · Full text

Public Health, Community Health, Maternal Health +17